A Dutch biotech creating nasal sprays to protect against the flu and coronavirus has raised an additional $70 million and acquired a nimble Singapore startup … ...
Germ season has been going great guns for months now but that doesn’t mean the illnesses are abating. Oh no, if anything, post-Christmas we seem to be sicker than ever. With the kids heading ...
“An improved vaccine would ideally generate a resident memory population in the nasal mucosa or at the site of entry itself,” von Andrian explained. Despite these benefits, questions about their ...
Our opinions are our own. Here is a list of our partners and here's how we make money. The investing information provided on this page is for educational purposes only. NerdWallet, Inc.
Vaccination has been an undeniable success in reducing the severity and lethality of pathogenic infections. However, the disconnect between the site of vaccination and the route of pathogen exposure, ...